Findlay Park Partners LLP Thermo Fisher Scientific Inc. Transaction History

Findlay Park Partners LLP

$9.71 Billion
Q3 2024

A detailed history of Findlay Park Partners LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Findlay Park Partners LLP holds 324,620 shares of TMO stock, worth $170 Million. This represents 2.07% of its overall portfolio holdings.

Number of Shares

324,620

Previous 287,920 12.75%

Holding current value

$170 Million

Previous $159 Million 26.11%

% of portfolio

2.07%

Previous 1.6%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$531.86 - $624.21 $19.5 Million - $22.9 Million	36,700 Added 12.75%	324,620 $201 Million
Q2 2024 Aug 13, 2024	SELL	$541.52 - $599.02 $1.19 Million - $1.32 Million	-2,200 Reduced 0.76%	287,920 $159 Million
Q1 2024 Apr 30, 2024	SELL	$528.82 - $599.43 $33.5 Million - $37.9 Million	-63,300 Reduced 17.91%	290,120 $169 Million
Q4 2023 Feb 07, 2024	SELL	$431.41 - $532.94 $1.65 Million - $2.04 Million	-3,824 Reduced 1.07%	353,420 $188 Million
Q3 2023 Nov 07, 2023	BUY	$498.29 - $574.41 $38 Million - $43.8 Million	76,231 Added 27.13%	357,244 $181 Million
Q2 2023 Aug 04, 2023	SELL	$508.46 - $591.13 $6.39 Million - $7.42 Million	-12,559 Reduced 4.28%	281,013 $147 Million
Q1 2023 May 05, 2023	SELL	$535.0 - $604.82 $7.89 Million - $8.92 Million	-14,753 Reduced 4.78%	293,572 $169 Million
Q4 2022 Feb 06, 2023	BUY	$484.71 - $571.37 $41.2 Million - $48.5 Million	84,960 Added 38.04%	308,325 $170 Million
Q3 2022 Nov 10, 2022	SELL	$507.19 - $604.49 $68 Million - $81 Million	-134,038 Reduced 37.5%	223,365 $113 Million
Q2 2022 Aug 09, 2022	SELL	$500.9 - $612.21 $860,546 - $1.05 Million	-1,718 Reduced 0.48%	357,403 $194 Million
Q3 2021 Nov 12, 2021	SELL	$509.53 - $609.78 $808,624 - $967,720	-1,587 Reduced 0.44%	359,121 $205 Million
Q2 2021 Aug 09, 2021	SELL	$441.0 - $508.24 $3.84 Million - $4.43 Million	-8,718 Reduced 2.36%	360,708 $182 Million
Q1 2021 May 14, 2021	SELL	$439.85 - $518.83 $85.1 Million - $100 Million	-193,542 Reduced 34.38%	369,426 $169 Million
Q4 2020 Feb 11, 2021	SELL	$435.06 - $527.66 $24.4 Million - $29.6 Million	-56,007 Reduced 9.05%	562,968 $262 Million
Q3 2020 Nov 10, 2020	SELL	$359.77 - $441.52 $11.2 Million - $13.7 Million	-31,025 Reduced 4.77%	618,975 $273 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $29.2 Million - $38.5 Million	-106,273 Reduced 14.05%	650,000 $236 Million
Q2 2019 Aug 07, 2019	SELL	$257.51 - $295.55 $30.6 Million - $35.1 Million	-118,727 Reduced 13.57%	756,273 $222 Million
Q4 2018 Feb 12, 2019	SELL	$208.47 - $251.98 $88.6 Million - $107 Million	-425,000 Reduced 32.69%	875,000 $196 Million
Q3 2018 Nov 07, 2018	SELL	$205.57 - $244.32 $46.3 Million - $55 Million	-225,000 Reduced 14.75%	1,300,000 $317 Million
Q2 2018 Aug 07, 2018	BUY	$203.14 - $219.53 $25.4 Million - $27.4 Million	125,000 Added 8.93%	1,525,000 $316 Million
Q1 2018 May 09, 2018	SELL	$192.98 - $224.11 $131 Million - $152 Million	-677,151 Reduced 32.6%	1,400,000 $289 Million
Q4 2017 Feb 08, 2018	SELL	$182.03 - $200.37 $5.46 Million - $6.01 Million	-30,000 Reduced 1.42%	2,077,151 $394 Million
Q3 2017 Nov 08, 2017	BUY	$171.74 - $194.04 $362 Million - $409 Million	2,107,151	2,107,151 $399 Million

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $205B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Findlay Park Partners LLP with notifications on news.

Account

Findlay Park Partners LLP Thermo Fisher Scientific Inc. Transaction History